Anhedonic and Anxiogenic Effects of Cytokine Exposure
- 1 January 1999
- book chapter
- Published by Springer Nature
- Vol. 461, 199-233
- https://doi.org/10.1007/978-0-585-37970-8_12
Abstract
It is abundantly clear that interactions occur between the immune, endocrine, central, and autonomic nervous systems. Immunologic manipulations (or products of an activated immune system, e.g., cytokines) affect neuroendocrine and central neurotransmitter processes, and conversely, neuroendocrine and central neurotransmitter alterations may impact on immune activity (Anisman, Zalcman, & Zacharko, 1993; Blalock, 1994; Dunn, 1990; Rivier, 1993; Rothwell & Hopkins, 1995). It has been posited that, among other things, the immune system acts like a sensory organ informing the brain of antigenic challenge (Blalock, 1984, 1994). Furthermore, given the nature of the neurochemical changes elicited by antigens and cytokines, it was suggested that immune activation may be interpreted by the CNS as a stressor (Anisman et al., 1993; Dunn, 1990; Dunn, Powell, Meitin, & Small, 1989). To be sure, the effects of systemic Stressors (e.g., those associated with viral insults, bacterial endotoxins, cytokines) are not entirely congruous with those elicited by processive stressors (i.e., those involving higher-order sensory processing, e.g., fear conditioning, exposure to a predator or novel environment) (Herman & Cullinan, 1997). Nevertheless, cytokines may be part of a regulatory loop that, by virtue of effects on CNS functioning, might influence behavioral outputs and may even contribute to the symptoms of behavioral pathologies, including mood and anxiety-related disorders (Anisman et al., 1993; Crnic, 1991). It is curious that while cytokines have found an increasingly greater role in immunotherapy, and may contribute to neurodegenerative processes (Rothwell, Luheshi, & Toulmond, 1996), limited attention has been devoted to behavioral analyses of these cytokines in animal studies.Keywords
This publication has 128 references indexed in Scilit:
- Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivoPublished by Elsevier ,2002
- Cytokine-to-brain communication: A review & analysis of alternative mechanismsPublished by Elsevier ,2000
- Endogenous Interleukin-1 Receptor Antagonist is NeuroprotectiveBiochemical and Biophysical Research Communications, 1997
- Comparative, behavioural and electrocortical effects of tumor necrosis factor-α and interleukin-1 microinjected into the locus coeruleus of ratLife Sciences, 1997
- In Vivo Regulation of the IL-1β System (Ligand, Receptors I and II, Receptor Accessory Protein, and Receptor Antagonist) and TNF-α mRNAs in Specific Brain RegionsBiochemical and Biophysical Research Communications, 1996
- Sleep and the immune systemInternational Journal of Immunopharmacology, 1995
- Systemic administration of interleukin-1 stimulates norepinerphrine release in the paraventricular nucleusLife Sciences, 1993
- Identification and characterization of receptors for tumor necrosis factor-α in the brainBiochemical and Biophysical Research Communications, 1991
- Immobilization stress induces interleukin-1β mRNA in the rat hypothalamusNeuroscience Letters, 1991
- Convulsants induce interleukin-1β messenger RNA in rat brainBiochemical and Biophysical Research Communications, 1990